Fabomotizole
CAS No. | 173352-21-1 | Cat. No. | BCP10366 |
Name | Fabomotizole | ||
Synonyms | CM346;CM-346;Afobazol;CM 346;Obenoxazine; | ||
Formula | C15H21N3O2S | M. Wt | 307.41 |
Description | Afobazole's mechanism of action remains poorly defined however, with GABAergic, NGF and BDNF release promoting, MT1 receptor antagonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Afobazole was shown to inhibit MAO-A reversibly and there might be also some involvement with serotonin receptors. Afobazole has found little clinical use outside of Russia and has not been evaluated by the FDA. | ||
Pathways | Others Pathway | ||
Targets | Others |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.